imiquimod has been researched along with chitosan in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 5 (55.56) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso, MJ; Díaz-Freitas, B; González-Fernández, Á; Peleteiro, M; Sanchez, A; Vicente, S | 1 |
| Beck, RC; Buffon, A; Chaves, PS; Contri, RV; D'Amore, CM; Frank, AG; Frank, LA; Guterres, SS; Pohlmann, AR | 1 |
| Adame, S; Adhami, VM; Babatunde, AS; Bharali, DJ; Chamcheu, JC; Esnault, S; Longley, BJ; Massey, RJ; Mousa, SA; Mukhtar, H; Siddiqui, IA; Wood, GS | 1 |
| Kandimalla, KK; Layek, B; Prabha, S; Rahman Nirzhor, SS; Rathi, S; Wiedmann, TS | 1 |
| Alvarez-Figueroa, MJ; Armijo-Escalona, N; Carrasco-Flores, EA; González-Aramundiz, JV; Narváez-Araya, D | 1 |
| Abdel-Mottaleb, MMA; Arafa, MG; El-Zaafarany, GM; Fereig, SA | 1 |
| Bai, Y; Fang, X; Fu, B; Huang, H; Li, X; Ma, C; Meng, Z; Miao, W; Qian, C; Ren, H; Tao, X; Wang, A; Yang, Z | 1 |
| Abourehab, MAS; Hazari, SA; Kesharwani, P; Sheikh, A; Tulbah, AS | 1 |
| Pu, S; Sun, L; Zhao, K; Zhou, D | 1 |
9 other study(ies) available for imiquimod and chitosan
| Article | Year |
|---|---|
Co-delivery of viral proteins and a TLR7 agonist from polysaccharide nanocapsules: a needle-free vaccination strategy.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Cell Line; Chitosan; Complement Activation; Female; Hepatitis B; Hepatitis B Surface Antigens; Imiquimod; Macrophages; Mice; Mice, Inbred BALB C; Nanocapsules; Toll-Like Receptor 7; Vaccination | 2013 |
The use of chitosan as cationic coating or gel vehicle for polymeric nanocapsules: Increasing penetration and adhesion of imiquimod in vaginal tissue.
Topics: Administration, Intravaginal; Aminoquinolines; Animals; Antineoplastic Agents; Cell Line, Tumor; Cellulose; Chitosan; Drug Carriers; Drug Compounding; Female; Gels; Humans; Imiquimod; Nanocapsules; Pharmaceutical Vehicles; Polyesters; Swine; Tissue Adhesives; Vagina | 2017 |
Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.
Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Antioxidants; Catechin; Cell Differentiation; Cells, Cultured; Chitosan; Dermatitis; Filaggrin Proteins; Humans; Imiquimod; Keratinocytes; Mice; Mice, Inbred BALB C; Nanoparticles; Psoriasis | 2018 |
Design, Development, and Characterization of Imiquimod-Loaded Chitosan Films for Topical Delivery.
Topics: Adjuvants, Immunologic; Administration, Topical; Chitosan; Drug Delivery Systems; Drug Design; Drug Liberation; Humans; Imiquimod; Organ Culture Techniques; Skin Absorption | 2019 |
Design of Chitosan Nanocapsules with Compritol 888 ATO® for Imiquimod Transdermal Administration. Evaluation of Their Skin Absorption by Raman Microscopy.
Topics: Administration, Cutaneous; Animals; Chitosan; Drug Delivery Systems; Fatty Acids; Imiquimod; Nanocapsules; Nonlinear Optical Microscopy; Skin; Skin Absorption; Swine | 2020 |
Tacrolimus-loaded chitosan nanoparticles for enhanced skin deposition and management of plaque psoriasis.
Topics: Administration, Cutaneous; Animals; Chitosan; Drug Carriers; Drug Liberation; Ear; Imiquimod; Immunosuppressive Agents; Mice, Inbred C57BL; Nanoparticles; Particle Size; Psoriasis; Rats, Sprague-Dawley; Skin; Tacrolimus | 2021 |
Tumor immunotherapy boosted by R837 nanocrystals through combining chemotherapy and mild hyperthermia.
Topics: Cell Line, Tumor; Chitosan; Humans; Hydrogels; Hyperthermia, Induced; Imiquimod; Immunotherapy; Melanoma; Nanoparticles | 2022 |
Self-assembled Gallic acid loaded lecithin-chitosan hybrid nanostructured gel as a potential tool against imiquimod-induced psoriasis.
Topics: Chitosan; Gallic Acid; Humans; Imiquimod; Lecithins; Nanoparticles; Particle Size; Psoriasis | 2023 |
Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice.
Topics: Animals; Cell Proliferation; Chitosan; Dermatitis; Disease Models, Animal; Imiquimod; Inflammation; Interleukin-17; Interleukin-6; Keratinocytes; Mice; Mice, Inbred BALB C; Nanoparticles; Psoriasis; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2023 |